The Valley Desk

NCT03737851 · Interventional trial

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

Overall registry status Completed

Phase 2

Conditions Multiple Sclerosis (MS)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov